Professor Aron Popovtzer
Head and neck oncologist. Professor Popovtzer is a unique Israeli specialist in ENT oncology and radiotherapy with many years of clinical experience.
Aron Popovtzer graduated from the Faculty of Medicine of the Hebrew University of Jerusalem. After university he continued his studies with a residency at Beilinson Hospital (Petah Tikva) in head and neck surgery. He completed a second specialization in oncology and radiology at the University of Michigan hospital in Ann Arbor and at Memorial Sloan Kettering Cancer Center in New York. The innovative techniques of brachytherapy and focused external-beam radiotherapy he mastered during these fellowships allow the doctor to diagnose and treat the disease comprehensively: from the point of view of an otolaryngologist, an oncologist and a radiotherapist, making him a universal specialist in this field.
Professor Popovtzer heads the Israeli Society of Head and Neck Oncology and is a member of the Israeli society of otolaryngologists.
Professor Popovtzer currently heads the only department in the country specializing in head and neck oncology, at the Davidoff Cancer Center of Rabin Medical Center. He is also deputy director of this center. The department's doctors, led by Aron Popovtzer, successfully fight neoplasms of the head and neck using unique organ-preserving technologies and world achievements in pharmacology.
Aron Popovtzer is a physician-researcher who works with Israeli scientists on developing new, and improving existing, methods of diagnosing and treating neoplasms in otorhinolaryngology, and is an active participant and speaker at international scientific conferences and symposia.
For many years Professor Popovtzer has combined clinical and research work with teaching on physician continuing-education courses at Rabin Medical Center, and also teaches clinical oncology at the Faculty of Medicine of Tel Aviv University.
- Diagnosis and comprehensive treatment of all types of head and neck cancer.
- Therapy for thyroid cancer.
- Adjuvant chemoradiotherapy for head and neck cancer.
- Therapy for late-stage laryngeal cancer.